Difficulty: Medium
Average Score: 69%
Practice
Which statement reageding phasespecific chemotherapeutic agents is correct? They
Correct answer
A
Rationale
In the context of ABVD chemotherapy drugs, understanding the concept of phasespecific chemotherapeutic agents is crucial. The correct statement, "They are most effective in one phase of the cell cycle (phase-specific)," is correct because certain chemotherapy drugs target specific phases of the cell cycle to exert their cytotoxic effects. This specificity allows for targeted destruction of rapidly dividing cancer cells while minimizing harm to normal cells.
Option B, "Are effective in all phases of the cell cycle," is incorrect because phase-specific agents specifically target cells in a particular phase, rather than being effective throughout all phases. Option C, "Are only effective in G0 phase," is also incorrect as these agents target actively dividing cells in different phases of the cell cycle. Option D, "Include the alkylating agents," is incorrect as alkylating agents are a different class of chemotherapy drugs that work through a different mechanism of action.
Educationally, understanding the mechanism of action of chemotherapy drugs, particularly phase-specific agents like those in ABVD, is essential for healthcare providers involved in cancer treatment. This knowledge helps in selecting the most appropriate treatment regimens, understanding potential side effects, and optimizing patient outcomes. By grasping these concepts, healthcare providers can deliver more personalized and effective care to cancer patients undergoing chemotherapy treatment.
Option B, "Are effective in all phases of the cell cycle," is incorrect because phase-specific agents specifically target cells in a particular phase, rather than being effective throughout all phases. Option C, "Are only effective in G0 phase," is also incorrect as these agents target actively dividing cells in different phases of the cell cycle. Option D, "Include the alkylating agents," is incorrect as alkylating agents are a different class of chemotherapy drugs that work through a different mechanism of action.
Educationally, understanding the mechanism of action of chemotherapy drugs, particularly phase-specific agents like those in ABVD, is essential for healthcare providers involved in cancer treatment. This knowledge helps in selecting the most appropriate treatment regimens, understanding potential side effects, and optimizing patient outcomes. By grasping these concepts, healthcare providers can deliver more personalized and effective care to cancer patients undergoing chemotherapy treatment.